natgillin/translations-raw huggingface dataset:
ed Trudexa 40 mg solution for injection in pre-filled syringe Adalimumab
Trudexa 40 mg raztopina za injiciranje v napolnjeni injekcijski brizgi
ris Store in a refrigerator.
Shranjujte v hladilniku.
tho 2.
za 2.
EXPIRY DATE
DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA lje Uporabno do:
r ge EXP {MM/ YYYY} 4.
{MM/ LLLL} vo 4.
BATCH NUMBER
ŠTEVILKA SERIJE do
102 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
102 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
ed Trudexa 40 mg injection
Trudexa 40 mg injekcija
ris Subcutaneous use
pro subkutana uporaba
LOT: lon 5.
Serija: vo
CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT no
VSEBINA, IZRAŽENA Z MASO, PROSTORNINO ALI ŠTEVILOM ENOT do
40 mg/ 0.8 ml
40 mg/ 0, 8 ml eā
ed 1.
t me 1.
Trudexa 40 mg solution for injection in pre-filled syringe with needleguard
Trudexa 40 mg raztopina za injiciranje v napolnjeni injekcijski brizgi s ščitnikom za iglo adalimumab
r Excipients: mannitol, citric acid monohydrate, sodium citrate, sodium dihydrogen phosphate
nja Pomožne snovi: manitol, citronska kislina monohidrat, natrijev citrat, natrijev dihidrogenfosfat dihidrat, natrijev hidrogenfosfat dihidrat, natrijev klorid, polisorbat 80, natrijev hidroksid in voda za injekcije.
1 pre-filled syringe containing 40 mg adalimumab no
1 napolnjena injekcijska brizga s 40 mg adalimumaba do
1 alcohol pad
1 alkoholni zloženec
METHOD AND ROUTE(S) OF ADMINISTRATION t uc
POSTOPEK IN POT( I) UPORABE ZDRAVILA eā
ed Trudexa 40 mg solution for injection in pre-filled syringe with needleguard Adalimumab
Trudexa 40 mg raztopina za injiciranje v napolnjeni injekcijski brizgi s ščitnikom za iglo
106 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
106 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
ed Trudexa 40 mg injection Subcutaneous use
Trudexa 40 mg injekcija subkutana uporaba
LOT: ge lon 5.
ŠTEVILKA SERIJE lje Serija: vo 5.
OTHER t uc rod lP i na dic Me
DRUGI PODATKI eā av nim ilo rav Zd
107 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
107 PODATKI NA ZUNANJI OVOJNINI
ed Trudexa 40 mg solution for injection in pre-filled pen Adalimumab
Trudexa 40 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku adalimumab
1 pre-filled pen, containing 40 mg adalimumab 1 alcohol pad no
1 napolnjen injekcijski peresnik s 40 mg adalimumaba do
au EU/ 1/ 03/ 257/ 007
EU/ 1/ 03/ 257/ 007
2 pre-filled pens, each containing 40 mg adalimumab 2 alcohol pads no
2 napolnjena injekcijska peresnika s po 40 mg adalimumaba do
au EU/ 1/ 03/ 257/ 008
EU/ 1/ 03/ 257/ 008
See leaflet for further information. lon 4.
Za nadaljne informacije glejte navodilo za uporabo. lje vo 4.
4 pre-filled pens, each containing 40 mg adalimumab 4 alcohol pads no
4 napolnjeni injekcijski peresniki s po 40 mg adalimumaba do
au EU/ 1/ 03/ 257/ 009
EU/ 1/ 03/ 257/ 009
6 pre-filled pens, each containing 40 mg adalimumab 6 alcohol pads no
6 napolnjenih injekcijskih peresnikov s po 40 mg adalimumaba do
au EU/ 1/ 03/ 257/ 010
EU/ 1/ 03/ 257/ 010
r LOT:
nja Serija:
14.
lje 14.
GENERAL CLASSIFICATION FOR SUPPLY ge lon Medicinal product subject to medical prescription. no
Izdaja zdravila je le na recept. vo do
INFORMATION IN BRAILLE t uc
PODATKI V BRAILLOVI PISAVI eā
ed Trudexa 40 mg solution for injection in pre-filled pen Adalimumab
Trudexa 40 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku
116 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
116 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
ris Subcutaneous use
Trudexa 40 mg injekcija subkutana uporaba
LOT: lon 5.
ŠTEVILKA SERIJE lje Serija: vo 5.
117 REMINDER STICKERS TEXT (included in pack)
117 BESEDILO ZA OPOZORILNE NALEPKE (priložene pakiranju)
Mark your calendar with the stickers provided to remind you of the date for your next dose.
t me S priloženimi nalepkami si na koledarju označite datum, ko morate vzeti naslednji odmerek.
ed ris tho
pro za nja lje vo do eā av nim ilo rav Zd
118 PATIENT ALERT CARD TEXT (NOT INCLUDED IN PACK OR AS PART OF THE PACKAGE LEAFLET)
118 BESEDILO BOLNIKOVE OPOZORILNE IZKAZNICE (ni priložena pakiranju ali navodiliu za uporabo)
ed This alert card contains important safety information that you need to be aware of before you are given Trudexa and during treatment with
me Pred zdravljenjem s Trudexo:
Prior to Trudexa treatment: • Trudexa should not be used if you have moderate to severe heart failure.
Ta opozorilna izkaznica vsebuje pomembne • Trudexe ne smete dobiti, če imate zmerno do varnostne informacije, s katerimi morate biti
During Trudexa treatment:
pro seznanjeni, preden prejmete Trudexo in med zdravljenjem z njo.
Show this card to any doctor involved in your treatment.
hudo srčno popuščanje.
• If you develop symptoms of heart failure (shortness of breath or swelling of the feet) seek medical attention immediately.
Med zdravljenjem s Trudexo: • • Če doživite simptome srčnega popuščanja To izkaznico pokažite vsakemu zdravniku, ki
au Dates of Trudexa treatment:
(težko dihanje ali otekanje nog), takoj
Trudexa increases the risk of getting infections.
za poiščite zdravniško pomoč.
Infections may progress more rapidly and be more severe.
Okužbe Datumi zdravljenja s Trudexo:
This includes tuberculosis.
Trudexa zvečuje tveganje za okužbe.
1 st injection: _______________________ Following injections: _______________________
1. injekcija: _______________________
r _______________________
nja lahko napredujejo hitreje in so hujše.
ge Prior to Trudexa treatment: • You should not be treated with Trudexa if you have a severe infection.
Naslednje injekcije: _______________________ _______________________
lon
Zelo pomembno je, da
_______________________ _______________________
_______________________ _______________________ • Za podrobnejše informacije glejte navodilo za uporabo Trudexe. •
It is very important that you tell your doctor if you have ever had tuberculosis, or if you have been in close contact with someone who has no
zdravniku poveste, če ste kadarkoli imeli do
• See the Trudexa package leaflet for more information. • Please make sure you also have a list of all your other medicines with you at any visit to
Poskrbite, da boste na vsak pregled pri
had tuberculosis.
tuberkulozo ali ste bili v tesnem stiku s kom, ki jo je imel.
a health care professional.
zdravniku prinesli spisek vseh drugih zdravil, ki jih uporabljate.
Tuberculin test: _______________ Chest X-ray: _______________ t
Tuberkulinski test:
Patient’ s Name: _____________________ Doctor’ s Name: _____________________
_______________
Doctor’ s Phone: _____________________ uc
Bolnikovo ime:
During Trudexa treatment:
____________________
• If you develop symptoms suggestive of •
Rentgenogram prsnih organov: ____________ Med zdravljenjem s Trudexo: av
Keep this card with you for 5 months after the
Zdravnikovo ime: ____________________ Zdravnikov telefon: ____________________
infections, such as fever, persistent cough, rod
• Če se pri vas pojavijo simptomi, ki
last Trudexa dose, since side effects may
nakazujejo okužbo, npr. zvišanje telesne temperature, trdovraten kašelj, hujšanje ali nim
Me
•
weight loss, or listlessness, seek medical attention immediately. lP i na dic
To izkaznico imejte pri sebi še 5 mesecev po zadnjem odmerku Trudexe, kajti neželeni
occur a long time after your last dose of Trudexa.
učinki se lahko pojavijo še dolgo časa po brezvoljnost, takoj poiščite zdravniško zadnjem odmerku tega zdravila. pomoč. ilo rav Zd
119 Me dic ina lP rod uc t
119 Zd rav ilo nim av eā
120 no B.
120 do vo lje B.
r
Trudexa 40 mg raztopina za injiciranje v viali adalimumab
au
t Pred uporabo natančno preberite navodilo!
PACKAGE LEAFLET:
- Navodilo shranite.
Trudexa 40 mg solution for injection in vials Adalimumab
- Zdravnik vam bo dal tudi opozorilno izkaznico bolnika.
ed Read all of this leaflet carefully before you start using this medicine. − Keep this leaflet.
informacije, s katerimi morate biti seznanjeni, preden prejmete Trudexo in med zdravljenjem z
ris information that you need to be aware of before you are given Trudexa and during treatment with Trudexa.
Izkaznico shranite skupaj z navodilom za uporabo.
Keep this Patient Alert Card together with the package leaflet. − If you have any further questions, please ask your doctor or pharmacist.
- Če imate dodatna vprašanja, se posvetujte z zdravnikom ali s farmacevtom.
tho − This medicine has been prescribed for you.
- Zdravilo je bilo predpisano vam osebno in ga ne smete dajati drugim.
It may harm them, even if their symptoms are the same as yours. − If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet,
- Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželeni učinek, ki ni
au please tell your doctor or pharmacist.
za omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
1.
nja 1.
Before you use Trudexa
Kaj je zdravilo Trudexa in za kaj ga uporabljamo 2.
ge 3.
Kaj morate vedeti, preden boste uporabili zdravilo Trudexa 3.
How to use Trudexa 4.
Kako uporabljati zdravilo Trudexa lje 4.
Possible side effects 5 How to store Trudexa lon 6.
Možni neželeni učinki 5 Shranjevanje zdravila Trudexa 6.
Further information
Dodatne informacije vo
WHAT TRUDEXA IS AND WHAT IT IS USED FOR no
KAJ JE ZDRAVILO TRUDEXA IN ZA KAJ GA UPORABLJAMO do
Monoclonal antibodies are t
Monoklonska protitelesa eā
Adalimumab binds to a specific protein uc
so beljakovine, ki prepoznajo druge specifične beljakovine in se nanje vežejo.
(tumour necrosis factor or TNFα), which is present at increased levels in inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. rod
Adalimumab se veže na specifično beljakovino (tumorje nekrotizirajoči faktor ali TNF), ki je pri vnetnih boleznih, kakršne so revmatoidni artritis, psoriatični artritis in ankilozirajoči spondilitis, prisoten v večji koncentraciji. av
If you have moderate to severe active rheumatoid arthritis, you may first be given other disease-modifying medicines, such as methotrexate. lP
Če imate zmeren do hud aktiven revmatoidni artritis, nim
If you do not respond well enough to these medicines, you will be given Trudexa to treat your rheumatoid arthritis. na
Če se na ta zdravila ne odzovete dovolj dobro, boste za zdravljenje revmatoidnega artritisa dobili Trudexo.
Trudexa can also be used to treat severe, active and progressive rheumatoid arthritis without previous methotrexate treatment. i
Trudexo je mogoče uporabljati tudi za zdravljenje hudega, aktivnega in napredujočega revmatoidnega artritisa brez predhodnega zdravljenja z metotreksatom. ilo
Trudexa has been shown to slow down the damage to the cartilage and bone of the joints caused by the dic
Dokazano je, da Trudexa upočasni okvaro sklepnega hrustanca in kosti, ki jo povzroča ta bolezen in rav
disease and to improve physical function.
izboljšuje telesno delovanje.
inappropriate, Trudexa can be given alone.
Zd
121 Ankylosing spondylitis
121 Ankilozirajoči spondilitis je vnetna bolezen hrbtenice.
ed Crohn’ s disease
Crohnova bolezen
ris Crohn’ s disease is an inflammatory disease of the digestive tract.
t Crohnova bolezen je vnetna bolezen prebavil.
If you have Crohn’ s disease you will first be given other medicines.
Če imate Crohnovo bolezen, boste najprej dobili druga
BEFORE YOU USE TRUDEXA
KAJ MORATE VEDETI, PREDEN BOSTE UPORABILI ZDRAVILO TRUDEXA
au Do not use Trudexa:
Ne uporabljajte zdravila Trudexa
• If you are allergic (hypersensitive) to adalimumab or any of the other ingredients of Trudexa.
za • če ste alergični na (preobčutljivi za) adalimumab ali katerokoli sestavino zdravila Trudexa.
r • If you have a severe infection, including active tuberculosis (see “ Take special care with
• če imate hudo okužbo, vključno z aktivno tuberkulozo (glejte "Bodite posebno pozorni pri uporabi Trudexe").
It is important that you tell your doctor if you have symptoms of infections, e. g. fever, wounds, feeling tired, dental problems. lon • If you have moderate or severe heart failure.
Pomembno je, da zdravniku poveste, če imate simptome okužb, npr. zvišano
It is important to tell your doctor if you have had or have a serious heart condition (see “ Take special care with Trudexa”).
nja telesno temperaturo, rane, občutek utrujenosti ali težave z zobmi.
Take special care with Trudexa: no
Pomembno je, da zdravniku poveste, če ste imeli ali lje imate kakšno resno bolezen srca (glejte "Bodite posebno pozorni pri uporabi Trudexe").
• If you experience allergic reactions such as chest tightness, wheezing, dizziness, swelling or rash do not inject more Trudexa and contact your doctor immediately. t
Bodite posebno pozorni pri uporabi Trudexe vo • Če doživite alergijske reakcije, npr. tiščanje v prsih, piskajoče dihanje, omotico, otekanje ali izpuščaj, Trudexe ne injicirajte več in se takoj posvetujte s svojim zdravnikom. do
The needle cover of the syringe contains natural rubber (latex).
• Pokrovček igle na brizgi vsebuje naravno gumo (lateks).
Patients who have a known sensitivity to latex should be advised to avoid touching the inner shield. rod
naročiti, da se ne smejo dotikati notranjega ščitnika.
• If you have an infection, including long-term or localized infection (for example, leg ulcer) consult your doctor before starting Trudexa.
• Če imate kakšno okužbo, vključno z dolgotrajno ali omejeno okužbo (npr. razjedo na nogi), se av
If you are unsure, please contact your doctor. lP
Če niste gotovi, se posvetujte s svojim zdravnikom.
• You might get infections more easily while you are receiving Trudexa treatment including serious infections, tuberculosis, opportunistic infections and sepsis that may, in rare cases, be life-threatening.
• Med zdravljenjem s Trudexo se lahko poveča dovzetnost za okužbe, vključno z resnimi nim
It is important to tell your doctor if you get symptoms such as fever, wounds, na
okužbami, tuberkulozo, oportunističnimi okužbami in sepso, ki so lahko v redkih primerih smrtno nevarne.
feeling tired or dental problems.
Pomembno je, da zdravniku poveste, če doživite simptome, kot so npr. zvišana telesna temperatura, rane, občutek utrujenosti ali težave z zobmi.
• As cases of tuberculosis have been reported in patients treated with Trudexa, your doctor will i
• Ker so bili pri bolnikih, zdravljenih s Trudexo, opisani primeri tuberkuloze, vas bo zdravnik ilo
This will include a dic
pred začetkom zdravljenja s Trudexo preiskal glede znakov in simptomov tuberkuloze.
thorough medical history, a chest X-ray and a tuberculin test.
To bo vključevalo natančno poizvedbo o vašem zdravju v preteklosti, rentgensko slikanje prsnih organov in tuberkulinski test.
The conduct of these tests should be recorded on your Patient Alert Card.
Izvedbo teh preiskav je treba zabeležiti na opozorilni izkaznici. rav
It is very important that you tell your doctor if you have ever had tuberculosis, or if you have been in close contact with someone who has had Me
Zelo pomembno je, da zdravniku poveste, če ste kadarkoli imeli tuberkulozo ali ste bili v tesnem stiku s kom, ki jo je imel.
If symptoms of tuberculosis (persistent cough, weight loss, listlessness, mild fever), or any other infection appear during or after therapy tell your doctor immediately.
Zd
Trudexa can cause reactivation of 122 HBV in people who carry this virus.
122 tega virusa.
ed • If you have multiple sclerosis, your doctor will decide if you should receive Trudexa.
me Če imate multiplo sklerozo, bo zdravnik presodil, ali lahko dobivate Trudexo.
Please check with your doctor
Preden opravite kakršnokoli cepljenje, se posvetujte z zdravnikom.
tho must be closely monitored by your doctor.
pro • Če imate blago srčno popuščanje in se zdravite s Trudexo, mora zdravnik natančno nadzorovati stanje vašega srčnega popuščanja.
au • In some patients the body may fail to produce enough of the blood cells that help your body fight infections or help you to stop bleeding.
za • Pri nekaterih bolnikih telo ne ustvari dovolj krvnih celic, ki pomagajo pri premagovanju okužbe ali ustavitvi krvavitve.
Your doctor may
Če dobite zvišano telesno temperaturo, ki ne mine, če se vam pojavljajo
r decide to stop treatment.
Morda se bo odločil, da vaše zdravljenje prekine.
ge • There have been very rare cases of certain kinds of cancer in patients taking Trudexa or other TNF blockers.
• Med bolniki, ki so jemali Trudexo ali druge zaviralce TNF, so se pojavili zelo redki primeri lje določenih vrst raka.
People with more serious rheumatoid arthritis that have had the disease for a lon long time may have a higher than average risk of getting a kind of cancer that affects the lymph system, called lymphoma.
Pri bolnikih z resnejšim revmatoidnim artritisom, ki imajo bolezen že dolgo, obstaja povečana verjetnost, da zbolijo za limfomom (rak limfatičnega sistema).
In addition very rare cases of non-melanoma skin cancer have been observed in patients taking Trudexa. no
Poleg tega so pri bolnikih, zdravljenih s Trudexo, vo opazili zelo redke primere nemelanomskega kožnega raka.
• Cancers, other than lymphoma, have been reported in patients with a specific type of lung disease called Chronic Obstructive Pulmonary Disease (COPD) treated with another TNF blocker.
• Pri bolnikih s posebno boleznijo pljuč, t. i. kronično obstruktivno pljučno boleznijo (KOPB), do
If you have COPD, or are a heavy smoker, you should discuss with your doctor whether treatment with a TNF blocker is appropriate for you. t uc
Če imate KOPB ali če veliko kadite, se morate z zdravnikom posvetovati, ali je zdravljenje z zaviralcem TNF za vas primerno. eā
Using other medicines
Uporaba drugih zdravil av
(sulfasalazine, hydroxychloroquine, leflunomide and injectable gold preparations), steroids or pain medications including non-steroidal anti-inflammatory drugs.
Trudexo se lahko uporablja skupaj z metotreksatom ali nekaterimi imunomodulirajočimi antirevmatičnimi zdravili (sulfasalazinom, hidroksiklorokinom, leflunomidom in pripravki zlata za injiciranje), steroidi in zdravili proti bolečinam, vključno z nesteroidnimi protivnetnimi zdravili. nim
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, lP
Obvestite svojega zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali katerokoli zdravilo, tudi če ste ga dobili brez recepta.
If you have na
Trudexe ne smete jemati z zdravili, ki vsebujejo učinkovino anakinro.
questions, please ask your doctor.
Če imate vprašanja, se posvetujte z zdravnikom. ilo
Using Trudexa with food and drink i dic
Uporaba zdravila Trudexa skupaj s hrano in pijačo rav
Pregnancy and breast-feeding Me
Nosečnost in dojenje Zd
123 If you are a breast-feeding mother, you should stop breast-feeding during Trudexa treatment and for at least 5 months after the last Trudexa treatment.
123 Če dojite, morate dojenje med zdravljenjem s Trudexo prekiniti in ne smete dojiti vsaj še 5 mesecev po zadnjem odmerku Trudexe.
ed Important information about some of the ingredients of Trudexa
t me Pomembne informacije o nekaterih sestavinah zdravila Trudexa
ris This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i. e. essentially ‘ sodium- free’.
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) v odmerku, kar pomeni, da je količina
Always take Trudexa exactly as your doctor has told you.
za Pri uporabi zdravila Trudexa natančno upoštevajte zdravnikova navodila.
au pharmacist if you are not sure.
Trudexa se injicira pod kožo (subkutana uporaba).
The usual dose for adults with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis is 40 mg adalimumab given every other week as
nja artritisom, psoriatičnim artritisom in ankilozirajočim spondilitisom je 40 mg adalimumaba vsak drugi teden v enkratnem odmerku.
The usual dose regimen for Crohn’ s disease is 80 mg at week 0 and followed by 40 mg every other week starting at week 2.
Običajna shema odmerjanja pri Crohnovi bolezni je 80 mg 0. teden, čemur sledi 40 mg vsak drugi teden od 2. tedna naprej.
In cases where a more rapid response is required your doctor may prescribe a dose of 160 mg at week 0 (as 4 injections in one day or 2 injections per day for two consecutive days), 80 mg (2 injections) at week 2, and thereafter as 40 mg (1 injection) every other lon week.
Kadar je potreben hitrejši odziv, vam zdravnik lje lahko predpiše odmerek 160 mg 0. teden (v 4 injekcijah na en dan ali v 2 injekcijah dva dni zapored), 80 mg (2 injekciji) 2. teden in potem 40 mg (1 injekcija) vsak drugi teden.
You should continue to inject Trudexa for as long as your doctor has told you.
Trudexo je treba injicirati toliko časa, vo kolikor vam je naročil zdravnik.
If your doctor determines that no
Če vaš zdravnik do
methotrexate is inappropriate, Trudexa can be given alone.
ugotovi, da metotreksat ni primeren, lahko Trudexo dobivate samo.
If you have rheumatoid arthritis and you do not receive methotrexate with your Trudexa therapy, your doctor may decide to give 40 mg adalimumab every week. t uc
Če imate revmatoidni artritis in če hkrati s Trudexo ne dobivate metotreksata, vam bo zdravnik morda predpisal 40 mg adalimumaba vsak teden. eā
Instructions for preparing and giving an injection of Trudexa: rod
Navodila za pripravo in injiciranje Trudexe av
After proper training, the injection can be self-administered or given by lP
Po nim
another person, for example a family member or friend.
ustreznem urjenju si lahko injekcije dajete sami ali vam jih daje kdo drug, npr. svojec ali prijatelj.
This injection should not be mixed in the same syringe or vial with any other medicine. na
Raztopine ne smete v isti brizgi ali viali mešati z nobenim drugim zdravilom.
1) Setting up
1) Priprava ilo
• Set up the following items on a clean surface
• Dobro si umijte roke. • Na čisto površino pripravite: rav
o o
• • •
One vial of Trudexa for injection One syringe with fixed needle
eno vialo Trudexe za injiciranje eno brizgo s fiksno iglo dva alkoholna zloženca
124 ed ris tho • Look at the expiry date on the vial.
124 t me pro • Preverite datum izteka roka uporabnosti na viali.
au 2) Choosing and preparing an injection site
za 2) Izbira in priprava injekcijskega mesta
• Choose a site on your thigh or stomach
nja • Izberite mesto na stegnu ali trebuhu.
no
lje vo do eā
• Each new injection should be given at least 3 cm from the last injection site. uc
• Vsako naslednjo injekcijo morate dati vsaj 3 cm od mesta prejšnje injekcije.
This may mean there is an infection.
Te spremembe lahko pomenijo okužbo. av
Wipe the injection site with the enclosed alcohol pad, using a circular motion. rod
S krožnim gibom obrišite injekcijsko mesto s priloženim alkoholnim zložencem.
3) Injecting Trudexa lP
3) Injiciranje Trudexe nim
Preparing the Trudexa dose for injection • Do NOT shake the vial. • Remove the plastic cap from the Trudexa vial.
Priprava odmerka Trudexe za injiciranje • Viale NE STRESAJTE. • Z viale Trudexe odstranite plastični pokrovček.
Do NOT remove the grey stopper or aluminium na
NE ODSTRANITE sivega zamaška ali aluminijastega obročka na vrhu viale. ilo
ring around the top of the vial. • Use a new alcohol pad to clean the grey stopper on the vial.
• Uporabite nov alkoholni zloženec in z njim očistite sivi zamašek viale.
After cleaning, do not touch the stopper with your hands. i
Po očiščenju se zamaška ne dotikajte več z rokami. rav
Remove cap from needle syringe, being careful not to touch needle or let it touch any surface. • Make sure that the plunger is fully inserted into the syringe.
• Odstranite pokrovček z igle na brizgi; pazite, da se igle pri tem ne dotaknete in da se z njo česa ne dotaknete. • Prepričajte se, da je bat do konca potisnjen v brizgo.
If the needle is correctly lined up, you should feel a slight resistance and then a “ pop” as the Me
Če je igla Zd
needle goes through the centre of the stopper.
pravilno naravnana, boste čutili rahel upor in potem "pok", ko igla predre osrednji del zamaška.
If this happens, do not use the syringe or vial.
Če se to zgodi, brizge ali viale ne uporabite. • Medtem ko je igla še vedno v viali, v višini oči obrnite vialo na glavo.
125 • With the needle still in the vial, turn the vial upside down at eye level.
125 • Medtem ko je igla še vedno v viali, preverite, ali so v brizgi zračni mehurčki.